Correction to “Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy”
In Figure 5C, the aPD-1/FCS and FBZ-BSA/FCS + aPD-1 (I.V.) groups on day 0, there was an overlap in the images of two mice.The reason is that when we took screenshots and saved them after analyzing the mouse imaging, the images were saved to the wrong folders.During our self-inspection, the software indicated that there was a risk of improper use of images, we immediately corrected the mistake by comparing it with the original data.We apologize for this error.Correction to "Figure 5C" In Figure 5C, the problematic images appeared in the aPD-1/FCS group.We apologize for this error.
Publication Details
- Journal
- Advanced Therapeutics
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1002/adtp.202500437
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00